tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Premier Anti-Aging Revises Earnings Forecast Amid Mixed Business Performance

Story Highlights
Premier Anti-Aging Revises Earnings Forecast Amid Mixed Business Performance

Elevate Your Investing Strategy:

An announcement from Premier Anti-Aging Co., Ltd. ( (JP:4934) ) is now available.

Premier Anti-Aging Co., Ltd. has revised its full-year consolidated earnings forecast for the fiscal year ending July 31, 2025, due to mixed performance across its business segments. While the recovery business through subsidiary Venex Co., Ltd. showed strong sales, the anti-aging segment underperformed, leading to an overall reduction in expected net sales. Despite this, operating profit exceeded expectations due to reduced advertising expenses and effective cost management. The company plans to invest in marketing for its renewed ‘DUO’ brand and new ‘Lalaskin’ skincare line, while remaining cautious about the challenging business environment, particularly in the Chinese market.

More about Premier Anti-Aging Co., Ltd.

Premier Anti-Aging Co., Ltd. operates in the beauty and wellness industry, focusing on anti-aging products and services. The company is known for its skincare brands, including ‘DUO’ and ‘Lalaskin,’ and has a market focus that includes both domestic and international markets, with particular attention to the Chinese market.

Average Trading Volume: 37,403

Technical Sentiment Signal: Buy

Current Market Cap: Yen8.24B

Learn more about 4934 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1